Free Trial

Invesco Ltd. Buys 13,263 Shares of Exponent, Inc. (NASDAQ:EXPO)

Exponent logo with Business Services background

Invesco Ltd. increased its holdings in Exponent, Inc. (NASDAQ:EXPO - Free Report) by 1.1% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,188,373 shares of the business services provider's stock after purchasing an additional 13,263 shares during the period. Invesco Ltd. owned approximately 2.34% of Exponent worth $105,884,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Westside Investment Management Inc. purchased a new position in shares of Exponent in the third quarter worth $26,000. Private Trust Co. NA raised its stake in Exponent by 129.8% in the fourth quarter. Private Trust Co. NA now owns 278 shares of the business services provider's stock worth $25,000 after buying an additional 157 shares in the last quarter. Atala Financial Inc purchased a new position in shares of Exponent in the 4th quarter valued at approximately $25,000. Tortoise Investment Management LLC boosted its position in shares of Exponent by 76.7% during the fourth quarter. Tortoise Investment Management LLC now owns 440 shares of the business services provider's stock valued at $39,000 after purchasing an additional 191 shares in the last quarter. Finally, Trust Co. of Vermont purchased a new stake in Exponent in the fourth quarter worth $45,000. Institutional investors own 92.37% of the company's stock.

Insider Buying and Selling at Exponent

In other news, VP Richard Reiss sold 1,736 shares of the firm's stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $85.93, for a total transaction of $149,174.48. Following the completion of the transaction, the vice president now directly owns 1,800 shares in the company, valued at $154,674. This trade represents a 49.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 2.10% of the company's stock.

Exponent Trading Down 1.4 %

Exponent stock traded down $1.11 on Friday, hitting $78.28. 302,366 shares of the stock traded hands, compared to its average volume of 242,306. Exponent, Inc. has a 1 year low of $73.83 and a 1 year high of $115.75. The firm has a market cap of $3.98 billion, a P/E ratio of 36.92 and a beta of 0.84. The business's fifty day simple moving average is $82.62 and its 200 day simple moving average is $92.46.

Exponent (NASDAQ:EXPO - Get Free Report) last issued its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.06. Exponent had a net margin of 19.52% and a return on equity of 27.27%. During the same period last year, the business posted $0.41 earnings per share. As a group, analysts predict that Exponent, Inc. will post 1.98 earnings per share for the current year.

Exponent Profile

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Featured Articles

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Should You Invest $1,000 in Exponent Right Now?

Before you consider Exponent, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.

While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Week Reveals a Rare Growth Story in a Shaky Market
Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines